Clearpoint Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Clearpoint Neuro
CLPT Stock  USD 10.93  0.31  2.76%   
Clearpoint Neuro financial statements provide useful quarterly and yearly information to potential Clearpoint Neuro investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Clearpoint Neuro financial statements helps investors assess Clearpoint Neuro's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Clearpoint Neuro's valuation are summarized below:
Gross Profit
13.5 M
Profit Margin
(0.60)
Market Capitalization
310.1 M
Enterprise Value Revenue
9.3298
Revenue
30.4 M
There are currently one hundred twenty fundamental signals for Clearpoint Neuro that can be evaluated and compared over time across rivals. All traders should validate Clearpoint Neuro's prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 165.8 M in 2024, whereas Market Cap is likely to drop slightly above 83.6 M in 2024.

Clearpoint Neuro Total Revenue

25.15 Million

Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 366.7 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 7.13, Dividend Yield of 0.0 or PTB Ratio of 8.29. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
  
Check out the analysis of Clearpoint Neuro Correlation against competitors.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Clearpoint Neuro Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding25.8 M24.6 M10.2 M
Slightly volatile
Total Assets23.2 M42.7 M20 M
Slightly volatile
Short and Long Term Debt Total9.9 M13.9 M9 M
Slightly volatile
Other Current Liabilities2.5 M3.6 M2.4 M
Very volatile
Total Current Liabilities4.7 M7.4 M6.4 M
Slightly volatile
Property Plant And Equipment Net5.2 M5 M1.7 M
Slightly volatile
Current Deferred Revenue2.7 M2.6 M1.1 M
Pretty Stable
Accounts Payable373.4 K393 K1.4 M
Slightly volatile
Cash14.1 M23.1 M12 M
Slightly volatile
Non Current Assets Total6.8 M6.5 M2.8 M
Slightly volatile
Non Currrent Assets Other582.8 K495 K688.6 K
Very volatile
Cash And Short Term Investments14.9 M23.1 M12.7 M
Slightly volatile
Net Receivables4.1 M3.9 M1.5 M
Slightly volatile
Common Stock Total Equity263.6 K221.4 K306.9 K
Slightly volatile
Liabilities And Stockholders Equity23.2 M42.7 M20 M
Slightly volatile
Non Current Liabilities Total9.6 M14.1 M8.9 M
Slightly volatile
Inventory8.3 M7.9 M3.4 M
Slightly volatile
Other Current Assets2.5 M2.4 M623.7 K
Slightly volatile
Other Stockholder Equity121.2 M193.4 M105.6 M
Slightly volatile
Total Liabilities16.1 M21.5 M15.4 M
Very volatile
Property Plant And Equipment Gross6.2 M5.9 M1.9 M
Slightly volatile
Total Current Assets20.4 M36.2 M17.6 M
Slightly volatile
Short Term Debt1.5 M848 K2 M
Slightly volatile
Common Stock258.6 K247 K308.3 K
Slightly volatile
Intangible Assets841.4 K1 M627.5 K
Pretty Stable
Other Assets1.3 M668.1 K1.1 M
Very volatile
Long Term Debt8.3 M9.9 M6.3 M
Slightly volatile
Long Term Debt Total7.9 M11.4 M6.4 M
Slightly volatile
Capital Surpluse137.6 M215.1 M118.1 M
Slightly volatile
Property Plant Equipment1.3 M1.4 M950.4 K
Slightly volatile
Other Liabilities505.7 K351 K611.1 K
Slightly volatile
Net Invested Capital28.7 M31.1 M19.1 M
Slightly volatile
Short and Long Term Debt1.6 M1.8 M2 M
Slightly volatile
Net Working Capital27 M28.7 M17.2 M
Slightly volatile
Capital Stock213.1 K247 K150.5 K
Slightly volatile
Capital Lease Obligations2.6 M4 M1.2 M
Slightly volatile
Deferred Long Term Liabilities318.6 K448.5 K252.4 K
Slightly volatile
Non Current Liabilities Other1.6 M1.4 M2.2 M
Slightly volatile

Clearpoint Neuro Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.5 M1.5 M513.4 K
Slightly volatile
Interest Expense366.7 K386 K1.1 M
Slightly volatile
Selling General Administrative7.5 M11.8 M6.8 M
Slightly volatile
Total Revenue25.2 M24 M10.3 M
Slightly volatile
Gross Profit14.3 M13.6 M6.6 M
Slightly volatile
Other Operating Expenses48.7 M46.4 M20.1 M
Slightly volatile
Research Development12.3 M11.7 M5.3 M
Slightly volatile
Cost Of Revenue10.9 M10.3 M3.7 M
Slightly volatile
Total Operating Expenses37.9 M36.1 M16.4 M
Slightly volatile
Income Tax Expense1.1 M1.3 M1.3 M
Slightly volatile
Interest Income624.8 K443.9 K447.9 K
Slightly volatile
Selling And Marketing Expenses7.3 M12.6 M5.4 M
Slightly volatile
Reconciled Depreciation1.2 M1.2 M347.3 K
Slightly volatile

Clearpoint Neuro Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation6.4 M6.1 M2.1 M
Slightly volatile
Begin Period Cash Flow29 M27.6 M11.8 M
Slightly volatile
Depreciation1.5 M1.5 M513 K
Slightly volatile
Capital Expenditures1.1 M1.1 M321.1 K
Slightly volatile
End Period Cash Flow13.2 M23.1 M12.1 M
Slightly volatile
Change To Netincome4.8 M4.6 M1.8 M
Slightly volatile
Dividends Paid254.4 K183.6 K388.4 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.136.97438.7898
Very volatile
Days Sales Outstanding42.9760.094351.9742
Very volatile
Average Payables688.5 K724.7 K1.3 M
Slightly volatile
Stock Based Compensation To Revenue0.230.25380.2137
Slightly volatile
Capex To Depreciation0.390.72130.4873
Slightly volatile
EV To Sales10.26.59039.0527
Very volatile
Inventory Turnover0.841.30721.0108
Slightly volatile
Days Of Inventory On Hand407279384
Slightly volatile
Payables Turnover27.6326.3138.3077
Slightly volatile
Sales General And Administrative To Revenue0.570.49080.6065
Slightly volatile
Average Inventory1.2 M1.6 M1.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.70.48880.6461
Slightly volatile
Capex To Revenue0.04610.04390.0245
Slightly volatile
Cash Per Share0.890.94051.6185
Pretty Stable
Days Payables Outstanding13.1813.8715468
Slightly volatile
Income Quality1.020.62110.9381
Pretty Stable
Intangibles To Total Assets0.02320.02440.052
Slightly volatile
Current Ratio3.024.86843.477
Slightly volatile
Receivables Turnover8.16.07387.5516
Pretty Stable
Graham Number3.964.169127.5517
Slightly volatile
Capex Per Share0.05720.04270.0524
Slightly volatile
Average Receivables684.5 K982.5 K899.9 K
Slightly volatile
Revenue Per Share0.920.97362.5175
Slightly volatile
Interest Debt Per Share0.40.42165.4859
Slightly volatile
Debt To Assets0.230.24310.7763
Slightly volatile
Operating Cycle466339437
Slightly volatile
Days Of Payables Outstanding13.1813.8715468
Slightly volatile
Ebt Per Ebit1.230.98411.1292
Pretty Stable
Quick Ratio2.53.80362.871
Slightly volatile
Net Income Per E B T1.261.161.1715
Very volatile
Cash Ratio2.113.11442.4267
Slightly volatile
Days Of Inventory Outstanding407279384
Slightly volatile
Days Of Sales Outstanding42.9760.094351.9742
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.821.07661.0134
Very volatile
Fixed Asset Turnover7.994.83659.3989
Pretty Stable
Debt Ratio0.230.24310.7763
Slightly volatile
Price Sales Ratio7.136.97438.7898
Very volatile
Asset Turnover0.690.56150.6761
Slightly volatile
Gross Profit Margin0.750.56830.6826
Slightly volatile

Clearpoint Neuro Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap83.6 M167.1 M88.4 M
Slightly volatile
Enterprise Value165.8 M157.9 M88.9 M
Slightly volatile

Clearpoint Fundamental Market Drivers

Cash And Short Term Investments23.1 M

Clearpoint Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Clearpoint Neuro Financial Statements

Clearpoint Neuro shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.6 M2.7 M
Total Revenue24 M25.2 M
Cost Of Revenue10.3 M10.9 M
Stock Based Compensation To Revenue 0.25  0.23 
Sales General And Administrative To Revenue 0.49  0.57 
Research And Ddevelopement To Revenue 0.49  0.70 
Capex To Revenue 0.04  0.05 
Revenue Per Share 0.97  0.92 
Ebit Per Revenue(0.94)(0.98)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY